Brief: Enveric Biosciences Announces New U.S. Patent For C4-Carboxylic Acid-Substituted Tryptamine Derivatives
05/09/2023 13:55
Enveric Biosciences Inc ENVB.O :
* ENVERIC BIOSCIENCES ANNOUNCES NEW U.S. PATENT FOR
C4-CARBOXYLIC
ACID-SUBSTITUTED TRYPTAMINE DERIVATIVES
Source text for Eikon: ID:nBw5T5XCXa
Further company coverage: ENVB.O
Recent news on Enveric Biosciences
See all newsBrief: Enveric Biosciences Announces Positive Results From IND-Enabling ADMET Studies
Enveric Biosciences Q2 net loss widens
AtaiBeckley surges after report Lilly poised to buy psychedelic drug developer
Brief: Enveric Biosciences Initiates Investigational New Drug (IND)-Enabling Genotoxicity Studies Of Lead Neuroplastogen Candidate EB-003
Brief: Enveric Biosciences Reports Positive Preclinical Results From Phototoxicity Analysis For Lead Neuroplastogen Candidate Eb-003